Schedule 13G ownership disclosure

CORREVIO PHARMA CORP

Security class unavailable · CUSIP: 22026V105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,092,133
Percent of class
8.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001421578-19-000011
Form type
SC 13G/A
Filer
Correvio Pharma Corp.
CIK
CIK 1036141
Filed
Feb 14, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub